Finance

Chad Robins, CEO of Adaptive Biotechnologies. Anjali Sundaram | CNBC Check out the companies making headlines after the bell. Adaptive Biotechnologies – The biotechnology company’s stock fell 5% in extended trading after Adaptive gave its first-quarter financial results. The company reported a loss of 25 cents per share on revenue of $20.9 million, while analysts
0 Comments
A worker examines cannabis plants at a Tilray farm. Source: Tilray Check out the companies making headlines after the bell. Novavax — The vaccine company’s stock skyrocketed 37% in extended trading after Novavax highlighted an outside investment of $388 million to advance the clinical development of its coronavirus vaccine candidate in its first-quarter earnings release. The
0 Comments
The world’s wealthiest could be subjected to higher tax rates as governments scramble to fund spending and repair their economies amid the coronavirus crisis, an economist has predicted. Speaking to CNBC’s “Street Signs Europe” on Monday, Roger Bootle, chairman of Capital Economics, said he was concerned that some governments — including Britain’s — would assume
0 Comments
Patrick Harker, President of Philadelphia Federal Reserve Bank, during the Fed’s annual Jackson Hole symposium in Wyoming. Gerard Miller | CNBC Philadelphia Federal Reserve President Patrick Harker warned Thursday that reopening the economy too quickly could have grave consequences. The central bank official posed two scenarios: The “more optimistic” one where the economy reopens in
0 Comments